Printer Friendly

BIOPLASTY, INC., ANNOUNCES RECEIPT OF PATENT INFRINGEMENT COMPLAINT

BIOPLASTY, INC., ANNOUNCES RECEIPT OF PATENT INFRINGEMENT COMPLAINT
 ST. PAUL, Minn., Nov. 27 /PRNewswire/ -- Bioplasty Inc. (NASDAQ: BIOP) announced today that it has been served with a lawsuit brought by McGhan Medical Corporation alleging that Bioplasty, Inc., certain of its officer and directors, and Bio-Manufacturing, Inc., are infringing on its United States Patent Nos. 4,455,691 and 4,455,226 relating to breast implant prosthesis.
 Bioplasty's CEO stated "It is the policy of the parties not to infringe on any valid patent rights of others, and we intend to defend this action vigorously."
 -0- 11/27/91
 /CONTACT: Arthur A. Beisang, CEO or Timothy P. Lawin, president, both of Bioplasty, 612-633-4112/
 (BIOP) CO: Bioplasty, Inc.; McGhan Medical Corporation; Bio-Manufacturing ST: Minnesota IN: MTC SU:


DS -- MN009 -- 7796 11/27/91 14:27 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 27, 1991
Words:134
Previous Article:REAL ESTATE OFFICIALS TO MEET WITH BUSH TO DISCUSS RECOVERY FOR NATIONAL ECONOMY
Next Article:SCRIPT SYSTEMS ANNOUNCES ACTION BY STOCKHOLDER GROUP
Topics:


Related Articles
INAMED BRINGS PATENT INFRINGEMENT SUIT AGAINST BIOPLASTY
BIOPLASTY RECEIVES BREAST IMPLANT PATENT
FDA CALLS FOR A UNITED STATES MORATORIUM ON SILICONE GEL-FILLED BREAST IMPLANTS
BIOPLASTY ANNOUNCES STOCK DIVIDEND
BIOPLASTY SUBMITS INVESTIGATIONAL DEVICE EXEMPTION (IDE) FOR ITS MISTI GOLD BREAST IMPLANTS
BIOPLASTY WITHDRAWS BREAST IMPLANTS OVERSEAS
BIOPLASTY SETTLES PATENT INFRINGEMENT SUIT
BIO-VASCULAR REPORTS DISPUTE ON ROYALTIES
BIOPLASTY SETTLES PATENT INFRINGEMENT SUIT
BIOPLASTY, INC. FILES FOR PROTECTION UNDER CHAPTER 11 OF THE U.S. BANKRUPTCY CODE

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters